The Evaluation of Iron Deficiency and Iron Overload.
Gattermann N, Muckenthaler MU, Kulozik AE, Metzgeroth G, Hastka J.
Dtsch Arztebl Int. 2021 Dec 10;118(49):847-856. doi: 10.3238/arztebl.m2021.0290.
Anemia and iron overload as prognostic markers of outcomes in beta-thalassemia.
Musallam KM, Sheth S, Cappellini MD, Forni GL, Maggio A, Taher AT.
Expert Rev Hematol. 2024 Sep;17(9):631-642. doi: 10.1080/17474086.2024.2383420. Epub 2024 Jul 26.
Ineffective Erythropoiesis: Anemia and Iron Overload.
Gupta R, Musallam KM, Taher AT, Rivella S.
Hematol Oncol Clin North Am. 2018 Apr;32(2):213-221. doi: 10.1016/j.hoc.2017.11.009. Epub 2017 Dec 29.
Hepcidin and Iron in Health and Disease.
Nemeth E, Ganz T.
Annu Rev Med. 2023 Jan 27;74:261-277. doi: 10.1146/annurev-med-043021-032816. Epub 2022 Jul 29.
Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.
Belmouhand M, Eckmann-Hansen C, Ilginis T, Leinøe EB, Mortensen BK, Larsen M.
BMC Ophthalmol. 2021 Jul 13;21(1):277. doi: 10.1186/s12886-021-02030-1.
Αlpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT.
Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3.
Iron metabolism and iron disorders revisited in the hepcidin era.
Camaschella C, Nai A, Silvestri L.
Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020.
Alpha- and Beta-thalassemia: Rapid Evidence Review.
Baird DC, Batten SH, Sparks SK.
Am Fam Physician. 2022 Mar 1;105(3):272-280.
The role of oral iron in the treatment of adults with iron deficiency.
Lo JO, Benson AE, Martens KL, Hedges MA, McMurry HS, DeLoughery T, Aslan JE, Shatzel JJ.
Eur J Haematol. 2023 Feb;110(2):123-130. doi: 10.1111/ejh.13892. Epub 2022 Nov 20.
How I treat non-transfusion-dependent β-thalassemia.
Saliba AN, Musallam KM, Taher AT.
Blood. 2023 Sep 14;142(11):949-960. doi: 10.1182/blood.2023020683.
